The malarial pathogen Plasmodium falciparum (Pf) is a member of the Apicomplexa, which independently evolved a highly specific lactate dehydrogenase (LDH) from an ancestral malate dehydrogenase (MDH) via a five-residue insertion in a key active site loop. PfLDH is widely considered an attractive drug target due to its unique active site. Apicomplexan loop conservation suggests that a particular insertion sequence was required to evolve LDH specificity, and we previously showed (Boucher 2014) that a tryptophan in the insertion, W107f, is essential for activity and specificity. However, the roles of other residues in the loop are currently unknown. Here we show that PfLDH activity is remarkably resilient to radical perturbations of both loop identity and length. Thus, alternative insertions could have evolved LDH specificity as long as they contained a tryptophan in the proper location. PfLDH therefore has high potential to develop resistance to drugs that target its distinctive active site.
Introduction
Apicomplexa are obligate, intracellular eukaryotic parasites of animals responsible for many human diseases, including malaria, cryptosporidiosis, babesiosis, cystoisosporiasis, cyclosporiasis, and toxoplasmosis. The organisms responsible for malaria are of the genus Plasmodium, with Plasmodium falciparum responsible for the most lethal form of malaria. P. falciparum proceeds through a complex life-cycle in two different hosts. P. falciparum sporozoites infect humans via a mosquito bite. These sporozoites invade liver cells, where they multiply asexually into merozoites. The merozoites rupture the liver cells and enter the bloodstream, where they invade erythrocytes and replicate. The replication of P. falciparum in erythrocytes is known as the blood stage of infection, which is largely responsible for the clinical symptoms of malaria [1] .
During the blood stage, P. falciparum must respire anaerobically to regenerate NAD + [1, 2] , an essential electron acceptor in glycolysis. In the presence of oxygen, ATP production is maximized by metabolizing glucose to CO2 and H2O via glycolysis, the citric acid cycle, and the electron transport chain, which regenerates NAD + for use in glycolysis. In the absence of oxygen, NAD + must be regenerated through pyruvate fermentation to prevent a stall in glycolysis and to generate sufficient amounts of ATP for cellular function. Lactate dehydrogenase (LDH) couples the regeneration of NAD + from NADH to the reduction of pyruvate to lactate. Since the blood stage of malarial infection occurs under anaerobic conditions, the Plasmodium falciparum LDH (PfLDH) is essential for the pathogen's survival as the only means to regenerate NAD + [2] .
Apicomplexan LDHs evolved from an ancestral α-proteobacterial malate dehydrogenase (MDH), independently of canonical LDHs such as those found in the metazoan hosts of apicomplexan parasites [3] . Despite convergent evolutionary origins, PfLDH and canonical LDHs both share a similar catalytic mechanism. The enzymatic reduction of pyruvate to lactate proceeds via the following steps: (1) starting in the "loop-open" conformation, NADH binds the apo enzyme, (2) R171 orients pyruvate in the active site to form the ternary complex, (3) the substrate specificity loop closes over the active site, allowing R109 to bind the substrate and stabilize the transition state, (4) NADH reduces pyruvate to lactate by hydride transfer, (5) the substrate specificity loop opens to release lactate, and (6) NAD + is released to regenerate the apo enzyme. D168 activates the catalytic H195, allowing for a proton transfer during the reduction of pyruvate to lactate (Figure 1a) . Movement of the substrate specificity loop is the rate-limiting step in catalysis [4] .
The LDH substrate specificity loop also plays an important role in substrate recognition.
This loop contains a residue at position 102, commonly referred to as the "specificity residue", which distinguishes among the R-groups of different 2-ketoacid substrates. In all known MDHs, the specificity residue is an arginine, which forms a salt bridge with the methylene carboxylate group of malate and oxaloacetate (Figure 1b) . In canonical LDHs the specificity residue is a glutamine, which contacts and recognizes the lactate and pyruvate methyl group (Figure 1b) .
However, the convergent apicomplexan LDHs did not evolve by a mutation at position 102.
Rather, apicomplexan LDHs evolved from an ancestral MDH via a unique five amino acid insertion in the substrate specificity loop that switches substrate specificity from malate/oxaloacetate to lactate/pyruvate [3] . The insertion lengthens the loop, but otherwise the structures of PfLDH and canonical LDHs and MDHs are highly similar (Figure 2a ).
Crystal structures of canonical LDHs with the substrate specificity loop in the closed
conformation show the Q102 specificity residue contacting substrate analogs (Figure 2b) . In contrast, the PfLDH crystal structure shows W107f contacting a substrate analog in the closed conformation, suggesting that W107f is the apicomplexan LDH "specificity residue" rather than the lysine at position 102 (Figure 2b) . Using point mutations and alanine scanning of the substrate specificity loop, we previously showed that W107f is essential for PfLDH enzyme activity and substrate recognition, while mutations of K102 have negligible effect [3] .
PfLDH is widely considered an attractive therapeutic target due to its essential role during pathogen replication in the blood stage and due to its distinct active site architecture, which provides an opportunity to selectively inhibit the parasite enzyme versus the host LDH.
Development of small molecule inhibitors against
PfLDH is currently an active area of research [2, [5] [6] [7] [8] [9] [10] [11] [12] [13] , and selective antibody inhibitors have been developed that target the unique PfLDH substrate specificity loop [14] . Sequence comparison of apicomplexan LDHs suggests the specificity loop region is highly conserved (Figure 3) . Hence, selective inhibitors of PfLDH are also likely to be effective against various Plasmodium strains and other apicomplexan LDHs (for example, as with Babesia [15] ).
The apparent sequence conservation of the substrate specificity loop poses an evolutionary problem: Was the conserved insertion sequence necessary for evolution of LDH specificity from the ancestral MDH? Furthermore, crystal structures show that much of the apicomplexan LDH loop bulges out into solution, lacking any clear structural role without contacting the rest of the protein. Was the entire five-residue insertion necessary, or could a shorter insertion have sufficed? To answer these questions, we probed the functional constraints on residue identity and loop length within the PfLDH substrate specificity loop by perturbation analysis. Loop conservation was quantified by estimating the evolutionary substitution rates across the loop, which identified several slow-evolving positions likely to be functionally constrained. With this information we generated an ensemble of PfLDH loop mutants and characterized their steady-state kinetics. We also made a series of mutants with varying loop lengths to characterize the functional dependence on loop length. Surprisingly, neither sequence identity nor loop length are under strong functional constraint, as long as W107f is unperturbed.
Methods

Site-Directed Mutagenesis
The Plasmodium falciparum lactate dehydrogenase (LDH) gene (gi#: 124513226) was synthesized and subcloned into pET-11b by GenScript (Piscataway, NJ) with a C-terminal 6xHis-Tag. All mutations and truncations were generated using a QuikChange Lightning kit (Agilent, Santa Clara, CA) with primers synthesized by Integrated DNA Technologies (Coralville, IA). All sequences were confirmed by Sanger Sequencing at Genewiz (Cambridge, Massachusetts). Conventional LDH numbering is based on the canonical dogfish LDH sequence, which has no insertion [16] . The residues in the apicomplexan insertion are thus numbered using the residue that precedes the insertion, K107, with letters appended to each residue sequentially: G106, K107a, S107b, D107c, K107d, E107e, W107f, and N108.
Protein Expression
Plasmids were transformed into BL21(DE3)pLysS Escherichia coli cells (Invitrogen, Grand Island, NY). Cells were grown at 37 °C and 225 RPM agitation in 2xYT media supplemented with 30mM potassium phosphate, pH 7.8 and 0.1% (w/v) glucose with cell growth monitored at OD600. When cultures reached OD600 0.5-0.8, cells were induced with 0.5mM IPTG and incubated for four hours at 37 °C and 225 RPM agitation. Cells were pelleted by centrifugation and stored at -80 °C.
Purification
Cell pellets were resuspended on ice in 25mL of 50mM sodium phosphate, pH 8. 
Kinetic Assays
All reagents were purchased from Sigma-Aldrich (St. Louis, MO). Initial rates for the conversion of pyruvate to lactate were monitored on a CARY 100 Bio spectrophotometer (Agilent, Santa Clara, CA) by following the decrease in absorbance at 340nm associated with the conversion of NADH to NAD + . Kinetics assays were performed with variable pyruvate 
Protein Crystallization, Data Collection, and Structure Determination
All reagents were used from Sigma-Aldrich (St. Louis, MO). Conditions were optimized based on promising conditions identified from screens with Crystal Screen TM and Crystal Screen 
Evolutionary Conservation Estimation
Apicomplexan LDH sequences were collected from the NCBI database using the BLASTP searches with four query sequences, UniProt IDs: MDHC_PIG, Q76NM3_PLAF7, C6KT25_PLAF, and MDH_WOLPM for full coverage of the superfamily. Non-LDH Sequences were removed along with sequences shorter than 290 or longer than 340. The final dataset contained 277 sequences. A multiple sequence alignment of the dataset was generated using Muscle and analyzed using PhyML [17] and ConSurf [18] . The relative conservation of each amino acid position within the alignment was estimated by quantifying the relative substitution rate using Empirical Bayes maximum likelihood methods.
Results
Contributions from Individual Specificity Loop Residues
We previously used alanine scanning mutagenesis to assess the functional contribution of individual residues within the specificity loop [3] . The boundaries of the scan were determined from a superposition of the human lactate dehydrogenase (LDH) and PfLDH (Figure 2b) . The main chains of the specificity loops in the two structures conformationally diverge between positions 101 and 108, a span of twelve residues. These twelve residues were individually mutated to alanine in PfLDH and characterized kinetically to evaluate the effects of each substitution on catalysis.
The alanine scan surprisingly revealed that all residues except W107fA tolerate mutation with little-to-no effect on their catalytic efficiency (kcat/KM, Figure 4a , as reported previously [3] ). W107fA has a four order of magnitude drop in kcat, indicating that W107f is essential for wild-type levels of strong catalysis. Notably, kcat remains relatively unaffected in all the other mutants (within a factor of two of the wild-type value). W107fA also has an increased KM, fifty times greater than wild-type. The remaining alanine mutants all have KM values within an order of magnitude relative to wild-type PfLDH (Figure 4b) .
The W107fA crystal structure (PDBID: 4PLZ, Supp. Table 6 ) was solved by molecular replacement and was found to have the same space group and cell dimensions as the wild-type PfLDH (PDBID: 1T2D) [3] . The W107fA structure is nearly identical to the wild-type protein (RMSD of 0.95 Å 2 , Figure 5a ). The only significant difference between W107A and wild-type is in the orientation of the specificity loop. The wild-type loop is in the closed conformation, indicated by a kinked helix running along the back of the protein (Figure 5b) . The W107fA mutant is in the open, non-catalytic conformation; indicated by the same helix in an unkinked linear conformation and disordered residues within the loop (Figure 5b ).
Conservative W107f mutations
As mutating a tryptophan to an alanine is a dramatic mutation, we wished to investigate the tolerance of position 107f to more conservative changes. W107f was mutated to various hydrophobic and aromatic residues, in addition to a glutamine which is the canonical LDH specificity residue [19] .
All W107f mutants had reduced enzymatic activity, with kcat/KM values for pyruvate ranging from fifty times lower to five orders of magnitude below that of wild-type. Both kcat and KM for pyruvate are affected. The large aromatic replacements, W107fY and W107fF, have the least effect, with 50-and 100-fold reductions in pyruvate activity, respectively (Figure 6a ).
While these aromatic mutations have a substantial effect, the resulting activities are likely physiologically relevant as they are similar to those of other wild-type LDHs in the apicomplexan phylum, which have kcat/KM values ranging from 10 4 to 10 7 [3, [20] [21] [22] [23] [24] [25] [26] .
The other W107f mutants have more diminished activities. The smaller histidine, while still an aromatic residue, cripples the enzyme a further fifty times below W107fF. The nonplanar hydrophobic amino acid mutants are all four orders of magnitude or more below the wildtype pyruvate kcat/KM, nearly on par with W107fA. Glutamine at position 107f is equally detrimental to pyruvate activity as the non-planar hydrophobics, despite being the specificity residue in canonical LDHs (Figure 6a) . The substitutions have substantial effects on both the kcat and KM except for W107fY and W107fF, both of which have a kcat within half of wild-type, and
W107fH, which has a KM nearly equal to wild-type (Figure 6b ).
Conservation of Loop Identity
Our alanine-scan mutants indicate most specificity loop residues are functionally unconstrained. This raises the question as to why the loop sequence is apparently wellconserved. High sequence conservation can arise for two main reasons, either (1) functional constraint to preserve the sequence or (2) insufficient time for the sequences to diverge.
Phylogenetic rate analysis can control for evolutionary relatedness. Low rates indicate functional importance due to purifying selection for sequences identity, high rates suggest low functional constraint. Our rate analysis indicates K102, K107a, and E107e within the loop are relatively slow-evolving and likely functionally important (Figure 7a) .
We designed two PfLDH mutant backgrounds to determine the role of the conserved residues. "Poly-A" and "Poly-S" mutants were constructed with all positions 101-107e mutated to alanine and serine, respectively (Figure 7b) . The alanine scan indicates that any position other than W107f can be mutated individually with minimal effect on activity. Mutations in combination may have a more significant effect, and the Poly-A and Poly-S constructs test this by mutating each position simultaneously. The more polar Poly-S should provide a less drastic sequence change for a solvent-exposed surface loop and may indicate if changes in Poly-A function are due to the increased hydrophobicity. W107f was left unchanged in both mutant backgrounds because the alanine scan and the W107f substitution data show that the identity of position 107f is highly constrained. Remarkably, both the Poly-A and Poly-S mutants retain LDH activity within approximately two orders of magnitude of wild-type PfLDH (Figure 8) , a level of activity observed in other apicomplexan LDHs such as the Toxoplasma gondii LDHs [25] .
We designed two additional mutants within the Poly-A background to determine the contributions from slow-evolving positions. If the loop residues are conserved due to functional constraint, there should be a partial rescue of activity when adding them back into the Poly-A mutant. The first construct "Cons" contains PfLDH wild-type residues at any loop position evolving slowly (defined as relative rate <1): T101, K102, P104, K107a, S107b, D107c, and E107e (Figure 7b) . Adding back the conserved residues partially restored activity by a factor of ten increase in kcat/KM compared to Poly-A (Figure 8) but is still ten-fold less than wild-type PfLDH activity. The second mutant "MaxCons" contains only the wild-type residues position that evolve as slowly as W107f (relative rate <0.4): K102, K107a, and E107e (Figure 7b) .
MaxCons behaved similarly to Cons despite having three fewer wild-type residues, suggesting that K102, K107a, E107e, and W107f are the most functionally important loop residues (Figure   8 ).
Tolerance of the Specificity Loop to Truncation
The five-residue loop insertion is unique to the apicomplexan LDHs, which makes their specificity loop longer than what is seen in canonical LDHs [19] . The existence of highly active canonical LDHs with shorter specificity loops raises the question of whether the large PfLDH loop is functionally necessary. Can PfLDH retain activity with a shortened specificity loop? We therefore designed and tested a series of loop deletion mutants, ranging from one to five residues, to assess the dependence of PfLDH activity on loop length (Figure 9) . Loop deletion mutants are named in the form of M(X) where X is the single letter amino acid code for the missing residues.
Additionally, the "GSA-Linker" construct incorporates a generic glycine-serine-alanine motif that connects T101 to W107f, making the shortest loop possible that retains W107f (based on the distance between the backbone Cαs of T101 and W107f). GSA-Linker is effectively a 6-residue deletion.
M(A), M(PG), M(PGK), exhibit between a 10-fold and 100-fold reduction in kcat/KM relative to wild-type (Figure 10a) Deleting three residues appears to be the largest loop truncation that is still well tolerated, with a kcat/KM > 10 4 . We next determined the kinetic effects of the position of the deleted residues in the loop by constructing and characterizing three-consecutive-residue loop truncations in all possible registers. All three-residue truncations had similar kinetics, with approximately a 100-fold reduction in kcat/KM, relative to wild-type, yet still within physiologically relevant range of activity (Figure 11 ).
Discussion
W107f is Under Extreme Functional Constraint
Alanine-scanning mutagenesis of the specificity loop revealed that only W107f contributes significantly to LDH activity (Figure 4) . Additionally, most of the alternative residues at the 107f position fail to replicate wild-type levels of activity. Only the other large aromatic residues, tyrosine and phenylalanine retain physiologically relevant activity, though still below wild-type PfLDH. (Figure 6) . These results show that only by mutating a large planar aromatic residue at the 107f position could have conferred LDH activity to the apicomplexan ancestral MDH, but without needing to be tryptophan.
Unlike the wild-type, the crystal structure of W107fA is in the open conformation, suggesting W107f contributes favorable interactions necessary for loop closure as the W107fA mutant apparently prefers the open state (Figure 5) . The rate-limiting step in pyruvate turn-over by PfLDH is loop closure [4] , and the reduction in kcat/KM for W107fA results primarily from a decrease in kcat. Taken together, these facts suggest that kcat of the W107fA mutant decreased because loop closure is slower. Given that KM = (koff+kcat)/kon, and the difference in mutant and wild-type KM is much smaller than the kcat effect, there must be some compensatory change in the binding constants of the substrate: either koff increased or kon decreased. We propose that loss of favorable interactions from W107f result in a loop that prefers to remain open in a conformation unfavorable for substrate binding, and thus substrate is ejected before hydride transfer takes place.
Conservation and Function Contribution of Specificity Loop Residues
Six of the ten loop residues evolve slower than average and thus may be functionally important (Figure 7a) . The contribution of the three slowest evolving (K102, K107a, and E107e) is however modest, a 10-fold increase in kcat/KM compared to a loop consisting entirely of alanines and W107f (Figure 8) . Activity is not further rescued by incorporating additional slowevolving wild-type residues.
Overall, PfLDH is roughly 50% sequence identical to LDHs from closely related Apicomplexa, such as Eimeria maxima and Toxoplasma gondii [3, 25, 27, 28] , yet the specificity loop region appears well-conserved. However, we find no obvious reason that the sequence and length of the specificity loop should be conserved, and in fact quantitive rate analysis indicates that most of the loop is not particularly slowly evolving. While the most conserved residues appear to contribute minimally to LDH function, it is possible the loop is important for another, unknown function. The loop sequence identity could be pleiotropically constrained if the enzyme is "moonlighting" [29, 30] and performs multiple functions for the organism (as seen in some vertebrate LDHs [31, 32] ).
The Specificity Loop can be Dramatically Truncated
The PfLDH specificity loop can be truncated by as many as four residues and still maintain significant levels of activity (Figure 10) . KM is affected by loop truncations more than kcat, with all truncation mutants exhibiting a KM an order of magnitude greater than wild-type, suggesting impaired substrate binding. Assuming kon is diffusion limited and is unlikely to be affected, the loop truncations effects are probably mediated by an increase in substrate koff due to a moderately unfavorable truncated loop conformation.
Loop deletion mutants may expose the active site to bulk solvent and increase the frequency of nonproductive binding events, which may explain why each of the three-residue deletion mutants all have approximately equal kcat/KM regardless of the location in the specificity loop or the identity of the residues removed. The size of substrate loop is more important than loop identity during catalysis. However, there is a lower limit to how short the loop can be to remain functional.
Evolutionary Requisites and Implications for Drug Resistance
Our results show that PfLDH activity is extremely robust to mutations in the specificity loop that alter either its sequence identity or length. In fact, only W107f appears to be particularly important for enzyme function, and yet other aromatic residues can function nearly Drug resistance can develop if the protein target is not functionally constrained. There are many possible specificity loops that can produce physiologically relevant LDH activities in P. falciparum. PfLDH thus has high potential to evolve mutations that could abolish any inhibitory effect of a drug that targets the active site loop because of the lack of significant functional constraint. The specificity loop region is conserved in the phylum and thus targeting the specificity loop in other Apicomplexa would likely be met with the same difficulties. WT 
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